News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
70,478 Results
Type
Article (11635)
Company Profile (32)
Press Release (58808)
Multimedia
Podcasts (47)
Webinars (6)
Section
Business (16886)
Career Advice (1653)
Deals (2885)
Drug Delivery (58)
Drug Development (8522)
Employer Resources (112)
FDA (1882)
Job Trends (2196)
News (32038)
Policy (4688)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (683)
Accelerated approval (14)
Adcomms (13)
Allergies (41)
Alliances (4359)
ALS (36)
Alzheimer's disease (262)
Antibody-drug conjugate (ADC) (62)
Approvals (1800)
Artificial intelligence (140)
Autoimmune disease (27)
Automation (8)
Bankruptcy (48)
Best Places to Work (1613)
BIOSECURE Act (11)
Biosimilars (34)
Biotechnology (22)
Bladder cancer (18)
Brain cancer (13)
Breast cancer (63)
Cancer (635)
Cardiovascular disease (66)
Career advice (1373)
Career pathing (35)
CAR-T (52)
CDC (28)
Cell therapy (169)
Cervical cancer (5)
Clinical research (6660)
Collaboration (255)
Company closure (3)
Compensation (65)
Complete response letters (23)
COVID-19 (784)
CRISPR (28)
C-suite (131)
Cystic fibrosis (16)
Data (784)
Decentralized trials (1)
Denatured (7)
Depression (44)
Dermatology (8)
Diabetes (106)
Diagnostics (699)
Digital health (8)
Diversity (5)
Diversity, equity & inclusion (29)
Drug discovery (69)
Drug pricing (95)
Drug shortages (13)
Duchenne muscular dystrophy (43)
Earnings (5054)
Editorial (60)
Employer branding (11)
Employer resources (103)
Events (8176)
Executive appointments (115)
FDA (2319)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (262)
Gene editing (55)
Generative AI (18)
Gene therapy (171)
GLP-1 (292)
Government (1092)
Grass and pollen (2)
Guidances (37)
Healthcare (2632)
HIV (26)
Huntington's disease (16)
IgA nephropathy (6)
Immunology and inflammation (69)
Immuno-oncology (21)
Indications (16)
Infectious disease (841)
Inflammatory bowel disease (23)
Inflation Reduction Act (5)
Influenza (21)
Intellectual property (21)
Interviews (323)
IPO (1091)
IRA (26)
Job creations (572)
Job search strategy (1112)
JPM (41)
Kidney cancer (2)
Labor market (62)
Layoffs (171)
Leadership (33)
Legal (1648)
Liver cancer (13)
Longevity (6)
Lung cancer (79)
Lymphoma (45)
Machine learning (18)
Management (42)
Manufacturing (184)
MASH (20)
Medical device (1297)
Medtech (1301)
Mergers & acquisitions (1915)
Metabolic disorders (353)
mRNA (77)
Multiple sclerosis (13)
NASH (4)
Neurodegenerative disease (73)
Neuropsychiatric disorders (25)
Neuroscience (486)
NextGen: Class of 2026 (1251)
Non-profit (954)
Now hiring (14)
Obesity (210)
Opinion (241)
Ovarian cancer (15)
Pain (38)
Pancreatic cancer (30)
Parkinson's disease (41)
Partnered (17)
Patents (56)
Patient recruitment (61)
Peanut (6)
People (5567)
Pharmaceutical (5)
Pharmacy benefit managers (10)
Phase 1 (2211)
Phase 2 (2889)
Phase 3 (2393)
Pipeline (817)
Policy (180)
Postmarket research (251)
Preclinical (848)
Press Release (8)
Prostate cancer (29)
Psychedelics (23)
Radiopharmaceuticals (33)
Rare diseases (264)
Real estate (802)
Recruiting (49)
Regulatory (2849)
Reports (10)
Research institute (536)
Resumes & cover letters (289)
Rett syndrome (7)
RNA editing (6)
RSV (13)
Schizophrenia (22)
Series A (49)
Series B (28)
Service/supplier (1)
Sickle cell disease (25)
Special edition (10)
Spinal muscular atrophy (20)
Sponsored (18)
Startups (552)
Stomach cancer (5)
Supply chain (26)
Tariffs (47)
The Weekly (39)
Vaccines (318)
Venture capital (52)
Weight loss (181)
Women's health (26)
Worklife (18)
Date
Today (5)
Last 7 days (75)
Last 30 days (316)
Last 365 days (3689)
2026 (940)
2025 (3701)
2024 (3721)
2023 (3862)
2022 (4866)
2021 (5707)
2020 (5675)
2019 (6141)
2018 (4815)
2017 (3585)
2016 (3793)
2015 (4185)
2014 (2789)
2013 (2154)
2012 (2397)
2011 (2456)
2010 (1672)
Location
Africa (324)
Alabama (7)
Alaska (1)
Arizona (15)
Arkansas (3)
Asia (3780)
Australia (897)
California (1365)
Canada (328)
China (116)
Colorado (49)
Connecticut (56)
Delaware (45)
Europe (9090)
Florida (153)
Georgia (24)
Idaho (5)
Illinois (98)
India (16)
Indiana (50)
Japan (46)
Kansas (23)
Kentucky (8)
Louisiana (9)
Maine (7)
Maryland (189)
Massachusetts (811)
Michigan (36)
Minnesota (43)
Mississippi (2)
Missouri (12)
Montana (5)
Nebraska (1)
Nevada (12)
New Hampshire (10)
New Jersey (288)
New Mexico (4)
New York (436)
North Carolina (106)
Northern California (589)
Ohio (38)
Oklahoma (5)
Oregon (5)
Pennsylvania (201)
Puerto Rico (1)
Rhode Island (6)
South America (346)
South Carolina (10)
Southern California (550)
Tennessee (17)
Texas (185)
United States (4322)
Utah (38)
Virginia (35)
Washington D.C. (19)
Washington State (67)
West Virginia (2)
Wisconsin (18)
70,478 Results for "just biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
Moderna’s Outright Flu Refusal Just the Latest Case of Crossed FDA Signals
The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is part of a larger communications crisis unfolding at the agency over the past nine months that has also ensnarled Sarepta, Capricor, uniQure and many more.
February 13, 2026
·
6 min read
·
Heather McKenzie
Press Releases
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
January 8, 2026
·
5 min read
Government
‘Just Agree to It:’ Pazdur Said He Was Told To Cosign FDA’s Reduced Trial Requirements
Richard Pazdur had spent 26 years at the FDA before stepping down last year due to disagreements with Commissioner Marty Makary about lowering the number of clinical trials required for a new drug application, Pazdur told the media.
February 16, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Evotec Closes Sale of Just - Evotec Biologics’ Toulouse Site to Sandoz
December 8, 2025
·
5 min read
Press Releases
Atara Biotherapeutics Provides a Business Update
February 23, 2026
·
4 min read
Press Releases
Sernova Biotherapeutics Announces Warrant Amendments
February 20, 2026
·
3 min read
Press Releases
Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel
March 3, 2026
·
4 min read
Press Releases
Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing
March 24, 2026
·
1 min read
Press Releases
Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months – Strengthening Global Protection for Breakthrough Proenzyme Formulations
January 28, 2026
·
4 min read
Press Releases
Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics
March 30, 2026
·
6 min read
1 of 7,048
Next
